News
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...
A first-in-human trial of Arvinas’ investigational Parkinson’s’ disease therapy, ARV-102, has been able to demonstrate a drop ...
Overview of HIV Drugs MarketThe Global HIV Drugs Market is valued at USD 34.75 Billion in 2024 and is projected to reach a ...
Forbes contributors publish independent expert analyses and insights. Hugh McIntyre covers music, with a focus on the global charts.
NEW HAVEN, Conn., March 27, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein ...
SAN FRANCISCO - OpenAI is making it easier to edit images in ChatGPT and create visuals for work that include lengthy, legible text, potentially broadening the chatbot’s appeal for businesses ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
A groundbreaking HIV clinical trial in Africa has demonstrated that some women can control the virus without antiretroviral therapy for extended periods after receiving a combination of treatments, ...
After 29 Matchweeks of the Premier League season, Opta Analyst's Ali Tweedale takes a look at the players who have dominated the physical charts in 2024/25 so far. It is a commonly held view among ...
Dar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without antiretroviral therapy for extended periods after receiving a combination of ...
As Congress gears up to pass President Trump’s massive legislative package, one of the biggest fights is over the future of Medicaid. To make their targeted budget numbers, Republicans will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results